The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Scioto Biosciences Closes $1.8M in Series A Financing
Finance

Scioto Biosciences Closes $1.8M in Series A Financing

MAY 21, 2018
New AZO Product Restores and Protects Vaginal Health
Pharma & Human Health

New AZO Product Restores and Protects Vaginal Health

MAY 17, 2018
Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children
Biotics and Supplements

Merck to Use Genome Editing in Study of Gut Bacteria to Benefit Malnourished Children

MAY 17, 2018
Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update
Finance

Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

MAY 16, 2018
Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing
Biotics and Supplements

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

MAY 16, 2018
Chr. Hansen reaches major milestone in innovation pipeline
Biotics and Supplements

Chr. Hansen reaches major milestone in innovation pipeline

MAY 16, 2018
Synlogic Announces Leadership Change
Biotics and Supplements

Synlogic Announces Leadership Change

MAY 11, 2018
Evelo Biosciences Announces Pricing of Initial Public Offering
Finance

Evelo Biosciences Announces Pricing of Initial Public Offering

MAY 10, 2018
Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech
Finance

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

MAY 9, 2018
DuPont Files Patent For the Use of Bacteria, Metabolites and Compositions for Blood Type Specific Probiotics
Biotics and Supplements

DuPont Files Patent For the Use of Bacteria, Metabolites and Compositions for Blood Type Specific Probiotics

MAY 9, 2018
FDA Clears 4D Pharma’s IND Application for Blautix
Pharma & Human Health

FDA Clears 4D Pharma’s IND Application for Blautix

MAY 9, 2018